Latest & greatest articles for colorectal cancer

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on colorectal cancer or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on colorectal cancer and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for colorectal cancer

81. DOP43 The risk of extra-intestinal cancer in inflammatory bowel disease (IBD): A systematic review and meta-analysis of population-based cohort studies Full Text available with Trip Pro

DOP43 The risk of extra-intestinal cancer in inflammatory bowel disease (IBD): A systematic review and meta-analysis of population-based cohort studies Validate User We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will take you to your content. Could not validate captcha. Please try again. Take me to my Content

2020 Journal of Crohn's and Colitis

82. Mechanistic and Therapeutic Advances in Colon Cancer: A Systematic Review Full Text available with Trip Pro

women, and early colonoscopy can be diagnosed early and treatment to improve survival rate [24]. Intestinal flora imbalance is associated with the development of many gastrointestinal diseases, such as inflammatory bowel disease (IBD), however patients with IBD, including Crohn’s disease (CD) and ulcerative colitis (UC), the risk of colon cancer is high and should be screened in time [25,26]. In addition to screening for patients with colon cancer-related symptoms, there are some special populations (...) of the morbidity. According to statistics, one third of the deaths from colon cancer are mostly people over 80 years old [6,7]. The early clinical symptoms of colon cancer often manifest as abdominal pain, diarrhea, adenomatous polyps, blood in the stool, anemia, thrombosis, spleen cyst, intestinal obstruction, etc., and intestinal obstruction is a complication of advanced cancer, which seriously affect people’s life and health [8-11]. The procedure of screening, diagnosis, metastasis, therapy and prevention

2019 Open Journal of Proteomics and Genomics

83. Prevalence of Human Papilloma Virus in Patients With Colorectal Cancer: A Systematic Review and Meta-analysis Full Text available with Trip Pro

Prevalence of Human Papilloma Virus in Patients With Colorectal Cancer: A Systematic Review and Meta-analysis Prevalence of Human Papilloma Virus in Patients With Colorectal Cancer: A Systematic Review and Meta-analysis '); document.write(' '); } ISSN : eISSN : Submitted: 07 May 2019 Revised: 14 Aug 2019 Accepted: 26 Oct 2019 First published online: 21 Dec 2019 (Enw Format - Win & Mac) (Bib Format - Win & Mac) (Ris Format - Mac only) (Ris Format - Win & Mac) (Txt Format - Win & Mac) (Ris Format (...) - Win & Mac) (Ris Format - Win & Mac) (Ris Format - Win & Mac) (Ris Format - Win only) (Refworks Format - Win & Mac) (Ris Format - FireFox Plugin) Int J Enteric Pathog . 2019; :106-112. doi: Abstract View: 556 PDF Download: 510 Review Article Prevalence of Human Papilloma Virus in Patients With Colorectal Cancer: A Systematic Review and Meta-analysis , , * Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran Department of Microbiology, School of Medicine

2019 International Journal of Enteric Pathogens

84. Investigating the Effect of Self-Care Training on Life Expectancy and Quality of Life in Patients with Gastrointestinal Cancer under Radiotherapy. Full Text available with Trip Pro

Investigating the Effect of Self-Care Training on Life Expectancy and Quality of Life in Patients with Gastrointestinal Cancer under Radiotherapy. A huge amount of the efforts made by health teams is dedicated to caring for cancer patients. This study has aimed to investigate the effect of self-care training on life expectancy and quality of life (QOL) in patients with gastrointestinal cancer who were under radiotherapy.In this clinical trial, 50 patients were selected using the block (...) training improved the QOL and life expectancy of patients with gastrointestinal cancer who were under radiotherapy. Therefore, self-care training is recommended to improve the QOL and the life expectancy of cancer patients.

2019 Asia-Pacific journal of oncology nursing Controlled trial quality: uncertain

85. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy Full Text available with Trip Pro

recommendations: an international comparison of high income countries . NHS. Bowel scope screening. . Navarro M , Nicolas A , Ferrandez A , Lanas A . Colorectal cancer population screening programs worldwide in 2016: An update . Levin TR , Corley DA , Jensen CD , et al . Effects of organized colorectal cancer screening on cancer incidence and mortality in a large community-based population . Cancer Research UK. Bowel cancer incidence statistics. . Danckert B FJ, Engholm G, Hansen HL, et al. NORDCAN: Cancer (...) the benefits and harms of different screening tests for their individual situation. Faecal testing with a faecal immunochemical test (FIT) every year Faecal testing with a faecal immunochemical test (FIT) every two years Endoscopic examination of only the lower part of the colon Endoscopic examination of the entire colon Favours no screening Favours screening Colonoscopy offered if FIT or sigmoidoscopy positive People with an estimated 15 year risk of colorectal cancer below 3% We suggest screening

2019 BMJ Rapid Recommendations

86. Colorectal Cancer

Editors © German Guideline Program in Oncology | Evidenced-based Guideline for Colorectal Cancer | Version 2.1 | Januar 2019 5 7.4.2.1. The Relevance of Individual Imaging Procedures (except PET) for the Evaluation of Distant Metastases in the Primary Treatment of CRC 109 7.4.2.2. Relevance of Pre-Operative Local Staging Using CT (MRI) for Colon Cancer with Regard to Local Spread 110 7.4.2.3. Relevance of PET-CT 110 7.4.2.3.1. For Primary Diagnosis of Colorectal Cancer 110 7.4.2.3.2. Before Resection (...) of Colorectal Liver Metastases 111 7.4.3. Tumor Markers 113 7.4.4. Specific Diagnostics for Rectal Cancer 114 7.5. Surgical Therapy with Curative Intention 117 7.5.1. Intraoperative Staging 117 7.5.1.1. Intra-Operative Pathological Examination 117 7.5.2. Radical Surgical Therapy of Colon Cancer 118 7.5.2.1. Extent of Lymph Node Dissection: 118 7.5.2.2. Complete Mesocolic Excision (CME) 120 7.5.2.3. Local Ablative Therapies for Liver Metastases 121 7.5.2.3.1. Radio-Frequency Ablation (RFA) 121 7.5.2.3.2

2019 German Guideline Program in Oncology

87. Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer

Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – European Society of Gastrointestinal Endoscopy (ESGE) +49-89-9077936-11 Menu DOI https://doi.org/10.1055/a-1016-4977 | Endoscopy 2019; 51:1082–1093 Published online: 9.10.2019 © Georg Thieme Verlag KG Stuttgart · New York Explore the ESGE website Menu Contact us +49 (...) -89-9077936-0 Follow us © 2004 - 2019 European Society of Gastrointestinal Endoscopy (ESGE). All Rights Reserved. |

2019 European Society of Gastrointestinal Endoscopy

88. Bevacizumab (Zirabev) - colorectal cancer, non-small cell lung cancer, peritoneal cancer, glioblastoma

Bevacizumab (Zirabev) - colorectal cancer, non-small cell lung cancer, peritoneal cancer, glioblastoma Search Page - Drug and Health Product Register Language selection Search and menus Search Search website Search Topics menu You are here: Summary Basis of Decision - - Health Canada Expand all Summary Basis of Decision (SBD) for Contact: Summary Basis of Decision (SBD) documents provide information related to the original authorization of a product. The for is located below. Recent Activity

2019 Health Canada - Drug and Health Product Register

89. Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer

Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline – European Society of Gastrointestinal Endoscopy (ESGE) +49-89-9077936-11 Menu DOI https://doi.org/10.1055/a-0831-2522 Endoscopy 2019; 51: 266–277 © Georg Thieme Verlag KG Stuttgart· New York Explore the ESGE (...) website Menu Contact us +49-89-9077936-0 Follow us © 2004 - 2019 European Society of Gastrointestinal Endoscopy (ESGE). All Rights Reserved. |

2019 European Society of Gastrointestinal Endoscopy

90. Management of urethral stricture due to prostate cancer and colorectal cancer radiotherapy: a systematic review Full Text available with Trip Pro

Management of urethral stricture due to prostate cancer and colorectal cancer radiotherapy: a systematic review Bali Medical Journal Published by DiscoverSys Inc Open Access & Peer Reviewed Multidisciplinary Journal of Medical Sciences MENU > ORIGINAL ARTICLE DOI: Management of urethral stricture due to prostate cancer and colorectal cancer radiotherapy: a systematic review Sirin Salsabila , Muhammad Adi Satrio Lazuardi, Kharisma Ogit Rosandy Sirin Salsabila Faculty of Medicine, Universitas (...) Brawijaya, Malang, Indonesia. Email: Muhammad Adi Satrio Lazuardi Pasuruan General Hospital, Pasuruan, Indonesia Kharisma Ogit Rosandy Prima Husada Hospital, Malang, Indonesia  | |  | Online First: December 01, 2019 | ​ Salsabila, S., Lazuardi, M., Rosandy, K. 2019. Management of urethral stricture due to prostate cancer and colorectal cancer radiotherapy: a systematic review. Bali Medical Journal 8 (3): 788-792. DOI:10.15562/bmj.v8i3.1612 Background : Prostate and colorectal cancer

2019 Bali Medical Journal

91. Variation in post-colonoscopy colorectal cancer across colonoscopy providers in English National Health Service: population based cohort study. Full Text available with Trip Pro

across NHS colonoscopy providers in England. The lowest incidence was seen in colonoscopies performed under the NHS bowel cancer screening programme. Quality improvement initiatives are needed to address this variation in rates and prevent colorectal cancer by enabling earlier diagnosis, removing premalignant polyps, and therefore improving outcomes.Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group (...) Variation in post-colonoscopy colorectal cancer across colonoscopy providers in English National Health Service: population based cohort study. To quantify post-colonoscopy colorectal cancer (PCCRC) rates in England by using recent World Endoscopy Organisation guidelines, compare incidence among colonoscopy providers, and explore associated factors that could benefit from quality improvement initiatives.Population based cohort study.National Health Service in England between 2005 and 2013.All

2019 BMJ

92. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians. Full Text available with Trip Pro

Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians. The purpose of this guidance statement is to guide clinicians on colorectal cancer screening in average-risk adults.This guidance statement is derived from a critical appraisal of guidelines on screening for colorectal cancer in average-risk adults and the evidence presented in these guidelines. National guidelines published in English between 1 June 2014 and 28 May (...) should screen for colorectal cancer in average-risk adults between the ages of 50 and 75 years.Clinicians should select the colorectal cancer screening test with the patient on the basis of a discussion of benefits, harms, costs, availability, frequency, and patient preferences. Suggested screening tests and intervals are fecal immunochemical testing or high-sensitivity guaiac-based fecal occult blood testing every 2 years, colonoscopy every 10 years, or flexible sigmoidoscopy every 10 years plus

2019 Annals of Internal Medicine

93. Bowel cancer screening: imaging use

screening: imaging use Information about imaging practice standards for bowel cancer screening of individuals unsuitable for a colonoscopy. Published 1 November 2012 Last updated 14 October 2019 — From: Documents Ref: PHE publications gateway number: GW-810 HTML Details This publication explains the use of whole colon imaging as an alternative to a colonoscopy as part of the NHS Bowel Cancer Screening Programme ( 14 October 2019 Added new guidelines on CTC imaging in NHS bowel cancer screening. 1 (...) Bowel cancer screening: imaging use Bowel cancer screening: imaging use - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote in the General Election on 12 December. Guidance Bowel cancer

2019 Public Health England

94. Phase II randomized clinical trial of endosonography and PET/CT versus clinical assessment only for follow-up after surgery for upper gastrointestinal cancer (EUFURO study) Full Text available with Trip Pro

Phase II randomized clinical trial of endosonography and PET/CT versus clinical assessment only for follow-up after surgery for upper gastrointestinal cancer (EUFURO study) Upper gastrointestinal malignancies have a poor prognosis. There is no consensus on how patients should be followed after surgery. The authors hypothesized that a structured follow-up programme including endoscopic ultrasonography (EUS) and [18 F]fluorodeoxyglucose (FDG) PET/CT would detect cancer recurrences, leading (...) chemotherapy (P = 0·028). Although survival after detection of recurrence in asymptomatic patients was significantly longer than that for symptomatic patients (P < 0·001), overall survival from date of surgery in the two treatment groups was comparable.Follow-up after surgery for upper gastrointestinal cancer with EUS and PET/CT leads to detection of more asymptomatic cancer recurrences and patients referred for treatment without prolonging overall survival. Registration number: NCT02209415 ( http

2019 EvidenceUpdates

95. Association Between Blood Circulating Vitamin D and Colorectal Cancer Risk in Asian Countries: A Systematic Review and Dose-Response Meta-analysis Full Text available with Trip Pro

Association Between Blood Circulating Vitamin D and Colorectal Cancer Risk in Asian Countries: A Systematic Review and Dose-Response Meta-analysis Association Between Blood Circulating Vitamin D and Colorectal Cancer Risk in Asian Countries: A Systematic Review and Dose-Response Meta-analysis | medRxiv Search for this keyword Association Between Blood Circulating Vitamin D and Colorectal Cancer Risk in Asian Countries: A Systematic Review and Dose-Response Meta-analysis Lin Zhang , Huachun Zou (...) , Chinese Academy of Medical Science & Peking Union Medical College , Beijing 100730, China For correspondence: Zhihong Qi 1 Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College , Beijing 100730, China For correspondence: ABSTRACT Objectives To assess the association between blood circulating Vitamin D levels and colorectal cancer risk in the Asian population. Design This is a systematic review and dose-response meta-analysis

2019 Cold Spring Harbor Laboratory

96. Colorectal cancer. (Abstract)

Colorectal cancer. Several decades ago, colorectal cancer was infrequently diagnosed. Nowadays, it is the world's fourth most deadly cancer with almost 900 000 deaths annually. Besides an ageing population and dietary habits of high-income countries, unfavourable risk factors such as obesity, lack of physical exercise, and smoking increase the risk of colorectal cancer. Advancements in pathophysiological understanding have increased the array of treatment options for local and advanced disease (...) only becomes symptomatic at an advanced stage, worldwide organised screening programmes are being implemented, which aim to increase early detection and reduce morbidity and mortality from colorectal cancer.Copyright © 2019 Elsevier Ltd. All rights reserved.

2019 Lancet

97. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer Full Text available with Trip Pro

A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint (...) on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer Chen Li, Xinli He, Lele Zhang, Lanying Li, Wenzhao Zhao Chen Li The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology Xinli He The First Affiliated Hospital, and College

2019 Research Square

98. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis Full Text available with Trip Pro

Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting (...) preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis Juli Lin, Jian-xian Lin, Chao-hui Zheng, Ping Li, Jian-wei Xie, Jia-bin Wang, Jun Lu, Qi-yue Chen, Long-Long Cao, Mi Lin, Chang-ming Huang Juli Lin Xiehe Affiliated Hospital

2019 Research Square

99. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study. Full Text available with Trip Pro

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study. To estimate benefits and harms of different colorectal cancer screening strategies, stratified by (baseline) 15-year colorectal cancer risk.Microsimulation modelling study using MIcrosimulation SCreening ANalysis-Colon (MISCAN-Colon).A parallel guideline committee (BMJ Rapid Recommendations) defined the time frame and screening interventions, including selection (...) of outcome measures.Norwegian men and women aged 50-79 years with varying 15-year colorectal cancer risk (1-7%).Four screening strategies were compared with no screening: biennial or annual faecal immunochemical test (FIT) or single sigmoidoscopy or colonoscopy at 100% adherence.Colorectal cancer mortality and incidence, burdens, and harms over 15 years of follow-up. The certainty of the evidence was assessed using the GRADE approach.Over 15 years of follow-up, screening individuals aged 50-79 at 3% risk

2019 BMJ

100. Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

for conducting a data audit. ? Sara Miller for copyediting. A complete list of the members of the GI DSG and the Working Group, with their affiliations and conflict of interest information, is provided in Appendix 2. Section 4: Evidence Review – September 8, 2015 Page 14 Guideline 2-29 Version 3: Section 4 Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: Evidence Review INTRODUCTION In Ontario, colorectal cancer is second only to lung cancer as a cause of cancer (...) stage III colon cancer [20]. Many questions remained about other therapies. In 2008, the Gastrointestinal Disease Site Group (GI DSG) developed a systematic review (SR) and clinical practice guideline on adjuvant systemic chemotherapy for stage II and III colon cancer following complete resection. The guideline recommended adjuvant chemotherapy for stage III patients [21]. For those with stage II disease, adjuvant chemotherapy was to be an option considered for the subset of patients with high-risk

2019 Cancer Care Ontario